Although CDKL4 exhibited similar risk estimate with recurrence in the validation set, the association did not reach statistical significance.
← all excerpts
High-throughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin.
1
—
—